Bleu, Melusine
Gaulis, Swann
Lopes, Rui
Sprouffske, Kathleen
Apfel, Verena
Holwerda, Sjoerd
Pregnolato, Marco
Yildiz, Umut http://orcid.org/0000-0002-7175-362X
Cordoʹ, Valentina http://orcid.org/0000-0003-1373-513X
Dost, Antonella F. M.
Knehr, Judith
Carbone, Walter
Lohmann, Felix
Lin, Charles Y. http://orcid.org/0000-0002-9155-090X
Bradner, James E. http://orcid.org/0000-0002-2718-4415
Kauffmann, Audrey
Tordella, Luca
Roma, Guglielmo http://orcid.org/0000-0002-8020-4219
Galli, Giorgio G. http://orcid.org/0000-0002-9401-060X
Article History
Received: 12 October 2018
Accepted: 30 July 2019
First Online: 20 August 2019
Competing interests
: All the authors affiliated with Novartis Institute of Biomedical Research are employees of Novartis. J.E.B. is now an executive and shareholder of Novartis AG, and has been a founder and shareholder of SHAPE (acquired by Medivir), Acetylon (acquired by Celgene), Tensha (acquired by Roche), Syros, Regency and C4 Therapeutics. The remaining authors declare no competing interests.